2022
DOI: 10.20473/jaki.v10i1.2022.99-110
|View full text |Cite
|
Sign up to set email alerts
|

Patterns of Medicine Use for Covid-19 Patients at Undata Hospital Palu

Abstract: Background: Covid-19 cases had drastically increased. Little therapy has been formulated to respond to the situation. Covid-19 symptoms in Indonesia are divided into four classes: asymptomatic, mild, moderate, and severe. Aims: This study aims to illustrate the pattern of drug use in Covid-19 patients at Undata Palu Hospital. Methods: This study is a type of cross-sectional descriptive study using a cross-sectional design and collecting data retrospectively from medical records at Undata Hospital Palu in 2020.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…In the interim, a greater proportion of patients who received favipiravir exhibited recovery compared to those who had mortality. 20 A study conducted in Bali also provides evidence supporting the efficacy of favipiravir in comparison to remdesivir and oseltamivir. The research was carried out over a duration of 14 days, including a total of 192 individuals.…”
Section: Table 2 Covid-19 Patients Length Of Staymentioning
confidence: 91%
“…In the interim, a greater proportion of patients who received favipiravir exhibited recovery compared to those who had mortality. 20 A study conducted in Bali also provides evidence supporting the efficacy of favipiravir in comparison to remdesivir and oseltamivir. The research was carried out over a duration of 14 days, including a total of 192 individuals.…”
Section: Table 2 Covid-19 Patients Length Of Staymentioning
confidence: 91%
“…Service standards are very much needed in an emergency such as a pandemic. Research conducted by (Rumi et al, 2022) explains how variations in the use of COVID-19 drugs are given.…”
mentioning
confidence: 99%